Eyes On Tomorrow

How did the UK’s first pioneers of IPL treatment for dry eyes make their mark? In this episode of Eyes on Tomorrow, we’re joined by renowned optometrists Connan Tam and Minakshi Jain, who share the journey that took them from working at Moorfields Eye Hospital and Great Ormond Street Hospital to establishing one of the UK’s leading dedicated Dry Eye Centres.

We explore some of the most exciting developments in dry eye care, including:
* The emerging role of tear film biomarkers and their connection to ocular and systemic disease
* How their IPL and low-level light (LLL) treatment protocols continue to evolve
* Where punctal occlusion fits into modern management, including their experience with Lacrifill canalicular gel
Connan and Minakshi also discuss why continuous learning is essential to delivering the very latest evidence-based treatments for patients.
And in the bonus episode for subscribers, they provide a practical, step-by-step guide to building a successful dry eye practice—from getting started with limited resources to scaling your clinic—and share the lessons they’ve learned, the mistakes to avoid, and the strategies that have helped them overcome common challenges.
Whether you’re passionate about ocular surface disease or looking to grow your own dry eye service, this episode is packed with practical insights, clinical pearls, and real-world advice.
This episode also features additional support from Nordic Pharma.
Get access to bonus episodes, along with a host of CPD resources, when you subscribe for only £25 per year at https://eyesontomorrow.substack.com/subscribe
Thanks to Topcon Healthcare and Thea UK for supporting Eyes on Tomorrow.
Produced by Matt Hill at Rethink Audio.


This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

What happens when one of the world’s best-known cataract surgeons sits down with Eyes on Tomorrow? You get an honest, insightful, and occasionally controversial conversation with the man behind Cataract Coach — Professor Uday Devgan.
Recorded in Galway, this episode goes beyond the operating microscope as Uday shares the philosophy behind his hugely influential “no secrets” approach to surgical education, the story of how Cataract Coach became a global phenomenon, and the lessons every young surgeon should hear about building a practice, managing patient expectations, and staying calm when complications strike.
We also dive into social media, surgical teaching on YouTube and Instagram, why ESCRS is the first meeting in his diary — and yes, whether FLACS is really for surgeons who can’t create a perfect rhexis.
In our subscriber bonus episode, we look ahead to the future of cataract surgery:
* Will robot-assisted surgery reduce complications?
* Are we finally getting closer to a truly accommodating IOL?
* And what innovations are actually worth the hype?
Always entertaining, always candid — this is The Cataract Coach Uncovered with Professor Uday Devgan.
Get access to bonus episodes, along with a host of CPD resources, when you subscribe for only £25 per year at https://eyesontomorrow.substack.com/subscribe
Thanks to Topcon Healthcare and Thea UK for supporting Eyes on Tomorrow.
Produced by Matt Hill at Rethink Audio.


This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

It’s our first episode dedicated to paediatric ophthalmology - and we’re joined by one of the world’s leading experts - Professor Ramesh Kekunnaya, Head of Paediatric Ophthalmology, Strabismus and Neuro-ophthalmology at the LV Prasad Eye Institute in Hyderabad, author of more than 250 publications, and one of the founding members of the World Society of Paediatric Ophthalmology and Strabismus.

This episode is packed with practical insights and the hottest topics shaping paediatric eye care today. We dive into:
• How Ramesh decides whether - and when - to implant an IOL in a child’s eye• The big question in infant cataract surgery: is it actually safer to wait longer?• What the WSPOS Myopia Consensus means for clinicians and parents navigating treatment options• How telemedicine and AI are transforming the screening and treatment of ROP
And we also go back to fundamentals - with Ramesh sharing his top tips for examining infants and young children, plus an inside look at how the LV Prasad network delivers eye care to an astonishing 30 million people.
And for subscribers, the Bonus episode goes even deeper:
• Emerging myopia treatments - from blue-light therapy delivered with virtual reality headsets to competing defocus technologies.• A customised approach to treatment: where to start, what to combine, and when to escalate• The role of peripheral refraction - and how to actually measure it• Red flags for syndromic and retinal dystrophy-related myopia
To access all Bonus episodes and our monthly newsletters, head to Eyes on Tomorrow on Substack
Special thanks to Topcon Healthcare and Théa UK for supporting the podcast - and to Matt Hill and the Rethink Audio team for bringing it all together.


This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

This month we’re bringing together three powerhouse women shaping the future of eye care: Purvi Thomson, Head Optometrist at OCL Vision; Bita Manzouri, Consultant Corneal and Cataract Surgeon and President-Elect of UKISCRS; and Elizabeth Lumb, Director of Global Professional Affairs, Myopia, at CooperVision.
Recorded just after International Women’s Day, this special panel episode is an honest, inspiring and thought-provoking conversation about the realities of leadership for women across optometry, ophthalmology and industry.
Together, they explore why visibility matters, how Covid transformed working patterns, the pressure of balancing careers and caregiving, and the crucial role played by mentors, allies and sponsors. They also tackle the persistent challenge of imposter syndrome and the unconscious bias that still exists in today’s workplace.
The message is clear: huge progress has been made over the past 20 years — but there is still more to do to ensure women can truly reach their full potential.
This is a conversation about resilience, change and what comes next.
Get access to bonus episodes, along with a host of CPD resources, when you subscribe for only £25 per year at https://eyesontomorrow.substack.com/subscribe
Thanks to Topcon Healthcare and Thea UK for supporting Eyes on Tomorrow.
Produced by Matt Hill at Rethink Audio.


This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

Are Neuroprotection and Neural Regeneration therapies coming of age? Professor Keith Martin, Director of the Centre for Eye Research Australia, shares how cutting-edge  research in neuroprotection and neural regeneration could transform how we treat glaucoma.

Tracing his journey from his PhD work with Harry Quigley in Baltimore, through the Cambridge Centre for Brain Repair, to leading CERA in Melbourne, Keith explores breakthroughs that move beyond pressure control — targeting the health and recovery of retinal ganglion cells themselves.

Emerging approaches include:

Delivering neurotrophic growth factors to protect retinal ganglion cells
Using Vitamin B3 to reduce oxidative stress
Activating intrinsic growth pathways to regenerate optic nerve axons
Transplanting stem-cell–derived retinal ganglion cells to restore lost vision

Keith also challenges long-standing practices in  glaucoma care. Are clinicians wasting time and resources  over-treating mild disease that may never threaten vision? And why are we still treating  primary open-angle glaucoma as one condition, rather than defining the distinct phenotypes and providing personalised therapy?

The future, he argues, lies in combination therapy: pairing traditional IOP control with regenerative and neuroprotective treatments to stop — and potentially reverse — vision loss.

Bonus Content
This month’s Bonus episode for subscribers includes insights into;

How OCT is reshaping glaucoma referrals in optometric practice
AI models outperforming specialists in predicting visual field loss from disc OCT appearances 
Home monitoring for IOP and visual fields
A promising new glaucoma device on the horizon
One thing is clear: the future of glaucoma care goes far beyond just lowering the IOP.
Get access to this Bonus episode, along with a host of CPD resources, when you subscribe for only £25 per year at https://eyesontomorrow.substack.com/subscribe
Thanks to Topcon Healthcare and Thea UK for supporting Eyes on Tomorrow.
Produced by Matt Hill at Rethink Audio.


This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe